Introduction β-and α 1 -adrenergic receptors (ARs) 1 play a critical role in the regulation of cardiac growth and function both at normal and diseased conditions (Post et al., 1999; Rockman et al, 2002) . Three subtypes of β-ARs, β 1 -AR, β 2 -AR and β 3 -AR, and at least two subtypes of α 1 -ARs, α 1A -AR and α 1B -AR, have been identified in the mammalian hearts. These receptors belong to the seven transmembrane spanning receptor superfamily coupled to heterotrimeric G proteins. β-ARs are coupled primarily to the stimulatory G protein Gs, whereas α 1 -ARs are coupled to the G protein Gq (Xiang and Kobilka, 2003; Zhu et al., 2001; Zhong and Minneman, 1999 ). The precise function of ARs is determined by their intracellular trafficking and targeting, which are highly coordinated by many regulatory factors at distinct organelles. ARs are synthesized in the ER and then transported to the plasma membrane through the Golgi apparatus where the receptors are post-translationally modified to attain mature status (Wu et al., 2003; Duvernay et al., 2005) . Once at the plasma membrane ARs may undergo internalization to the endosome upon stimulation by their ligands. Receptor internalization involves phosphorylation by at least two kinases, protein kinase A and G protein receptor kinases and subsequent binding of the phosphorylated receptors to arrestins, which serves as adaptor proteins recruiting components of the transport machinery to the clathrin-coated pits and initiating formation of the early endosome (Krupnik and Benovic 1998; Baillie et al., 2003) . The internalized receptors in the early endosome may be sorted in cardiac myocytes and its role in the regulation of receptor function and in the development of cardiac disease remain largely unknown. Several studies have demonstrated that homo-and hetero-dimerization of ARs may be required for their export from the ER and subsequent transport to the cell surface (Xu et al., 2003; Salahpour et al., 2004; Zhou et al., 2005) . For example, heterodimerization of α 1B -AR or β 2 -AR with α 1D -AR enhances the cell-surface expression of α 1D -AR (Hague et al., 2003; Hague et al., 2004; Uberti et al., 2005) . In addition, N-linked glycosylation of the receptors may also play important roles in targeting receptors to the cell surface as well as other specific transport pathways (Duvernay et al., 2005) .
Rab proteins are Ras-like small GTPases that coordinate protein transport in almost every discrete step of the secretory and endocytic pathways (Takai et al., 2001; Martinez and Goud, 1998; Plutner et al., 1991) . To date, 63 Rab GTPases have been identified in mammalian cells each with an unique subcellular localization and mediating protein transport at specific steps (Takai et al., 2001 ). For example, Rab5 specifically mediates the transport of G protein-coupled receptors from the plasma membrane to the early endosome and Rab4 is involved in the recycling of internalized receptors from the endosome to the plasma membrane (Seachrist and Ferguson 2003; Takai et al., 2001) . Rab1 is localized in the ER and Golgi and exclusively regulates antegrade protein transport specifically from the ER to the Golgi and between the Golgi compartments (Plutner et al., 1991; Tisdale et al., 1992; Allan et al., 2000) . We previously demonstrated that β 2 -AR transport from the ER through the Golgi to the cell surface in HEK293T cells is dependent on Rab1, whereas α 2B -AR transport to the cell surface is independent of Rab1 (Wu et al., 2003) . In this report, we determined the role of Rab1 in the cell surface targeting and signaling of distinct endogenous AR subtypes in cardiomyocytes. Our results demonstrate that cell surface expression and function of β-AR and α 1 -AR are similarly attenuated by inhibiting Rab1 function, but are differentially augmented by enhancing Rab1 function. These data indicate that the cultured in DMEM medium and infected with control parent adenovirus or adenovirus expressing Rab1 or its dominant-negative mutant Rab1N124I at a multiplicity of infection (MOI) of 20. After 48 h infection, expression of Rab1 was determined by Western blotting using a FLAG high-affinity monoclonal antibody. Fluorescent microscopic analyses following immunostaining with anti-FLAG antibodies revealed that greater then 95% of the cardiomyocytes were infected (Filipeanu et al., 2004) .
To determine if adenoviral expression of Rab1 could induce cell death, cardiac myocytes viability was measured using Calcein-AM retention and de-esterification as described (Yacovlev et al., 2000) . The data indicate that adenoviral expression of wild-type Rab1 or Rab1N124I in neonatal cardiomyocytes did not significantly influence cell viability (wild-type Rab1-intected cells: 86 ± 7 % and Rab1N124I-infected cells: 93 ± 2 % relative to control virus-infected cells, n=4, p > 0.05).
Measurement of Cell Surface
Receptors -Cell-surface expression of β-AR and α 1 -AR in neonatal cardiomyocytes was measured by intact cell ligand binding as described (Ricci et al., 1999; Calls et al, 2000; McLean et al., 1999) (β 1 -AR), niguldipine (α 1A -AR) or CEC (α 1B -AR) (10 µM). Non-specific binding was determined in the presence of alprenolol (β-AR) or phentolamine (β-AR) (20 µM) and accounted for less than 10% of the total binding. The cells were washed twice with ice cold PBS and digested with 1 ml of 1 M NaOH. All ligand binding assays were performed in triplicate. The radioactivity was counted by liquid scintillation spectrometry.
This article has not been copyedited and formatted. The final version may differ from this version. Measurement of ERK1/2 Activation -Activation of ERK1/2 was measured as described previously (Wu et al., 2003; Filipeanu et al., 2004) . Myocytes were cultured on 6-well plates at a density of 1 X 10 6 cells/well and infected for 48 h. Myocytes were stimulated with PE (10 µM) or ISO (10 µΜ) for 8 min with or without pretreatment with the AR antagonists ICI 115,881 or atenolol (100 nM) for 30 min. The reaction was terminated by the addition of 600 µl of 1 X SDS gel loading buffer. After solubilizing the cells, 30 µl of total cell lysates was separated by 10% SDS-PAGE. ERK1/2 activation was determined by immunoblotting to measure their phosphorylation with phospho-specific antibodies. The membranes were stripped and reprobed with anti-ERK1/2 antibodies to determine the total amount of kinases and to confirm equal loading of proteins. The signal was detected using ECL Plus (PerkinElmer Life Sciences) and a Fuji Film luminescent image analyzer (LAS-1000 Plus) and quantitated using the Image Gauge program (Version 3.4).
[ 3 H]-Leucine Incorporation -Protein synthesis rate was determined as described (Thaik et al., 1995; van Kesteren et al., 1997) . Briefly, neonatal cardiomyocytes were plated in 12-well dishes at a density of 5 X 10 5 /well in DMEM supplemented with 10% fetal bovine serum. After infection with the desired construct, the myocytes were made quiescent by incubation in DMEM without fetal bovine serum for 48 h. The cardiomyocytes were then incubated with [ 3 H]-leucine (1 µCi) for 24 h at 37 °C in the presence or absence of the AR agonists ISO (10 µM) or PE (10 µM) with or without ICI 115,881 or atenolol. The reaction was terminated by aspirating the medium. The cardiomyocytes were washed twice with 1 ml of 5% trichloroacetic acid followed by an extraction with 1 ml of 5% trichloroacetic acid for 1 h in ice to remove non-incorporated [ 3 H]-leucine. The cells were digested with 1 ml of 1 M NaOH for 6 h. The lysate was transferred to scintillation vials, neutralized with 1 ml of 1 M HCl, and counted by liquid This article has not been copyedited and formatted. The final version may differ from this version. Fluorescent Microscopy -Cardiomyocytes were grown on coverslips in 6-well dishes and infected with control, Rab1 or Rab1N124I adenoviruses as described above. After 10 h infection, the medium was removed and the myocytes were transiently transfected using LipofectAMINE 2000 reagent (Invitrogen)
as described previously (Wu et al., 2003; Filipeanu et al., 2004) . One µg of AR tagged with GFP with or without 1 µg of pDsRed2-ER construct were diluted into 125 µl of serum-free Opti-MEM in a tube. In another tube, 5 µl of LipofectAMINE was diluted into 125 µl of serum-free Opti-MEM. Five min latter both solutions were mixed and incubated for another 20 min. The transfection mixture was added to culture dishes containing 0.8 ml of fresh Dulbecco's modified Eagle's medium and 10% fetal bovine serum without antibiotics. After transfection 36-48 h, the myocytes were fixed with a mixture of 4% paraformaldehyde and 4% sucrose in PBS for 15 min. The coverslips were mounted, and fluorescence was detected with a Leica DMRA2 epifluorescence microscope (Filipeanu et al., 2004; Duvernay et al., 2004) . Images were deconvolved using SlideBook software and the nearest-neighbors deconvolution algorithm (Intelligent Imaging Innovations, Denver, CO) as described (Filipeanu et al., 2004) . Based on the GFP signal, approximately 5% myocytes were transfected by this plasmid transfection protocol. Control and Rab1 siRNA were delivered into neonatal cardiomyocytes using LipofectAMINE 2000 reagent. as described previously (Wu et al., 2003) . Briefly, 8 µl of LipofectAMINE 2000 and 6 µl of 20 µM siRNA were added separately to 100 µl of Opti-MEM. After incubation for 5 min, both solutions were mixed for 20 min. The transfection mixture was then added to the adenovirus-infected cardiac myocytes. The cells were incubated with the transfection mixture for 8 h and then medium was changed to standard culture medium. After 36-48 h the cells were processed for fluorescence microscopy as described above.
Statistical Analysis -Differences were evaluated using Student's t test, and p < 0.05 was considered as statistically significant. Data are expressed as the mean ± S.E.
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RESULTS

Differential Regulation by Rab1 of β-AR and α 1 -AR Expression at the Cell Surface in Cardiomyocytes
To determine whether Rab1 modulated export trafficking of endogenous ARs, we first determined the effect of transient expression of Rab1 and its dominant negative mutant Rab1N124I on the cell-surface expression of β-AR and α 1 -AR in primary cultures of neonatal rat ventricular myocytes.
Myocytes were infected with control, Rab1 or dominant-negative mutant, Rab1N124I, adenoviruses ( Klausner et al., 1992; Yoo et al., 2002) . Similar to the effect induced by adenoviral expression of Rab1N124I, BFA treatment reduced cell-surface numbers of total β-AR and total α 1 -AR ( Fig. 2A ). As expression of wild-type Rab1 selectively increased the cell-surface expression of α 1 -AR, we determined if BFA treatment could antagonize the effect of Rab1 on α 1 -AR transport. Rab1-mediated increase in α 1 -AR expression at the cell surface was significantly blocked by BFA treatment (Fig. 2B ).
Furthermore, α 1 -AR expression at the cell surface was further attenuated by BFA treatment in myocytes infected with Rab1N124. These data further indicate that the ER-to-Golgi transport plays an important role in the cell-surface targeting of β-AR and α 1 -AR.
Regulation by Rab1 of Cell-surface Expression of Individual AR Subtypes in Cardiomyocytes
As β-AR and α 1 -AR each has multiple subtypes in cardiomyocytes, we sought to define β-AR and α 1 -AR subtypes, whose transport from the ER to the cell surface is regulated by Rab1. Cell surface expression of β 1 -AR, β 2 -AR, α 1A -AR and α 1B -AR, predominant β-AR and α 1 -AR subtypes in cardiomyocytes, was determined by ligand binding in the presence of the AR subtype-selective antagonists atenolol, ICI 118,551, niguldipine and CEC, respectively. Cell-surface expression of β 1 -AR and β 2 -AR was markedly inhibited by adenovirus-mediated expression of Rab1N124I, but were not altered by wild-type Rab1 (Fig. 3 ). Similar to β 1 -AR and β 2 -AR, cell-surface expression of α 1A -AR and α 1B -AR was also inhibited by Rab1N124I. In contrast to β 1 -AR and β 2 -AR, cell surface expression of α 1A -AR and α 1B -AR was increased by adenoviral expression of Rab1 (Fig. 3) . These data are consistent with the effects of Rab1 on total β-AR and total α 1 -AR expression at the cell surface and indicate that Rab1 regulation of export trafficking from the ER to the cell surface is undistinguishable between β 1 -AR and β 2 -AR and between α 1A -AR and α 1B -AR.
This article has not been copyedited and formatted. The final version may differ from this version. We then determined the effect of Rab1 on the subcellular localization of the ARs. To this end, GFP-tagged β 2 -AR and α 1B -AR were transiently transfected into neonatal cardiomyocytes after infection with control or Rab1N124I adenoviruses. The subcellular distribution of the GFP-tagged receptors at steady state was revealed by fluorescent microscopy. As anticipated, β 2 -AR-GFP and α 1B -AR-GFP were mainly localized at the cell surface in myocytes infected with control adenovirus. In contrast, β 2 -AR-GFP and α 1B -AR-GFP were accumulated in the perinuclear regions and unable to transport to the cell surface in myocytes infected with Rab1N124I (Fig. 4A ). These receptors were strongly co-localized with the ER marker pDsRed2 (Fig. 4B) , consistent with the Rab1 function in regulating protein transport form the ER to the Golgi.
In the second series of experiment, we determined the effect of siRNA-mediated depletion of (Fig. 4C ). These data strongly indicated that normal Rab1 level is required for the transport of β 2 -AR and α 1B -AR transport to the cell surface.
Modulation of β-AR and α 1 -AR Signaling by Rab1 in Neonatal Cardiomyocytes
To determine whether Rab1 is capable of regulating AR signaling through modifying export trafficking of the receptors, we determined the effect of Rab1 on AR-mediated ERK1/2 activation.
Neonatal myocytes infected with control, Rab1 and Rab1N124I adenovirus were stimulated with the non-selective β-AR agonist ISO in the absence or presence of atenolol or ICI 118,551. ERK1/2 activation in response to stimulation with the AR agonists was evaluated by measuring their This article has not been copyedited and formatted. The final version may differ from this version. phosphorylation. ISO-mediated ERK1/2 activation in the absence or presence of the antagonists was similarly inhibited in cardiomyocytes infected with Rab1N124I, but was not altered in cardiomyocytes infected with Rab1 as compared with control adenovirus-infected myocytes (Fig. 5) . In contrast, PEmediated ERK1/2 activation was attenuated by Rab1N124I and augmented by Rab1 (Fig. 5) , suggesting that augmentation of Rab1 function by overexpressing Rab1 may selectively regulate AR signaling.
These data are consistent with Rab1 effects on the cell surface expression of the receptors and indicate that Rab1 modulates not only AR traffic, but also their signal transduction.
Effect of Rab1 on β-AR-and α 1 -AR-mediated Hypertrophic Response in Neonatal Cardiomyocytes
Our preceding data indicated that adenovirus-mediated expression of Rab1 selectively regulates the cell surface expression and signaling of ARs. We then determined if manipulation of Rab1 function could influence hypertrophic growth by measuring total protein synthesis and sarcomeric organization in response to the agonists ISO and PE in cardiomyocytes. PE effects on protein synthesis were significantly increased by 54% in cardiomyocytes expressing Rab1 compared with cardiomyocytes infected with control adenovirus (Fig. 6A) . In contrast, Rab1 had no influence on the protein synthesis in response to stimulation with ISO in the absence or presence of β 1 -and β 2 -AR antagonists (Fig. 6A) .
Total protein synthesis obtained from myocytes infected with parent adenoviral vector were close to that obtained from non-infected myocytes (data not shown), suggesting that influence of Rab1 infection on the protein synthesis could not be attributed to non-specific effects of adenoviral infection.
In contrast to Rab1, expression of the dominant negative mutant Rab1N124I significantly attenuated total protein synthesis in response to both agonists ISO and PE (Fig. 6A) . Increases in total protein synthesis in response to stimulation with ISO and PE were markedly attenuated in This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 6A) . Furthermore, Rab1N124I infection inhibited sarcomeric organization in response to stimulation with both ISO and PE (Fig. 6B ). These data indicate that the reduction of Rab1 function prevents AR-mediated cardiomyocyte hypertrophic growth, consistent with a decrease in cell-surface expression and signaling of ARs induced by the dominant negative mutant Rab1N124I in cardiomyocytes.
DISCUSSION
The most significant finding in this report is that augmentation of Rab1 function by adenovirusmediated expression of wild-type Rab1 selectively influenced export trafficking of endogenous β-and α 1 -ARs in neonatal ventricular myocytes. Overexpression of Rab1 significantly augmented the total cell-surface number of α 1 -AR as measured by intact cell ligand binding. In contrast, Rab1 expression had no significant influence on the total cell surface number of β-AR. Consistent with total AR expression, the cell-surface numbers of α 1A -AR and α 1B -AR subtypes were largely increased, whereas the cell-surface numbers of β 1 -AR and β 2 -AR subtypes were not altered by Rab1. These data strongly indicate that increased Rab1 function facilitates the cell-surface targeting of α 1 -AR subtypes, but not β-AR subtypes. These data also suggest a novel way to selectively increase cell-surface expression of endogenous α 1 -AR.
There are several possibilities regarding the selective regulation of β-AR and α 1 -AR export to the cell surface by Rab1. First, the ER-to-Golgi transport of β-AR and α 1 -AR may be mediated through distinct ER-derived vesicles, which are differentially regulated by Rab1. Consistent with this possibility, different proteins or isoforms have been reported to segregate into distinct vesicles (Muniz et al., 2001 ).
Second, transport of β-AR and α 1 -AR to the cell surface in cardiomyocytes may be mediated through distinct pathways, in which the level of endogenous Rab1 is a rate-limiting factor for the ER-to-Golgi transport of α 1 -AR, but not β-AR. However we cannot exclude the possibility that Rab1 also facilitated the ER-to-Golgi transport of β-AR, but did not significantly alter β-AR expression at the cell surface as the Golgi-to-cell surface transport is a rate-limiting step for β-AR export. Third, structural differences in distinct ARs may contribute to their regulation by Rab1. We previously demonstrated that the transport of α 2B -AR from the ER to the cell surface in HEK293T cells is independent of Rab1 (Wu et al., 2003) . Present work demonstrated that Rab1-mediated ER-to Golgi transport is required for cell surface targeting of all AR subtypes examined (i. e. α 1A -, α 1B -, β 1 -and β 2 -ARs). The cell-surface number of total β-AR and total α 1 -AR as well as individual α 1A -AR, α 1B -AR, β 1 -AR and β 2 -AR as measured by radioligand binding was significantly attenuated by adenoviral expression of the dominant negative mutant Rab1N124I in cardiomyocytes. It is unknown which intracellular compartments the receptors are exactly coming from in ligand binding experiments. However, the subcellular localization of GFPconjugated ARs reflects the effect of Rab1 on the newly synthesized receptors, as GFP-receptors were delivered into the cell after Rab1 infection. Importantly, Rab1 is one of the most extensively studied and best characterized Rab GTPase, which localizes to the ER and the Golgi and regulates protein transport between these two organelles. Therefore, the influence of Rab1 on the cell surface receptor expression is presumably through modulating the ER-to-Golgi transport of the receptor.
Microscopy analysis of subcellular localization of GFP-conjugated receptors, which were delivered into cardiomyocytes after Rab1 infection, indicated expression of Rab1N124I induced an accumulation of α 1B -AR and β 2 -AR in the ER. A similar behavior was observed when endogenous Rab1
This article has not been copyedited and formatted. The final version may differ from this version. was depleted using siRNA. Furthermore, BFA treatment, which impairs Golgi function and blocks the ER-to-Golgi protein transport (Klausner et al., 1992; Yoo et al., 2002) , inhibited the transport of α 1 -AR and β-AR to the cell surface and attenuated Rab1-induced enhancement of α 1 -AR expression at the cell surface. These data suggest that β-AR and α 1 -AR transport from the ER to the cell surface is mediated through the Rab1-dependend pathway and that Rab1 is involved in the transport from the ER to the Golgi.
Another important finding is that the functional response to β-AR and α 1 -AR stimulation can be modulated by manipulating their transport along the early secretory pathway. Adenoviral expression of Rab1 markedly and selectively augmented ERK1/2 activation in response to stimulation with the α 1 -AR agonist PE, but not to the β-AR agonist ISO in cardiomyocytes. Rab1N124I almost abolished the ERK1/2 activation by both α 1 -AR and β-AR agonists. These data indicate that Rab1 can differentially regulate signaling of α1-AR and β-AR in cardiomyocytes, which was due to the influence of Rab1 on the transport of the receptors from the ER to the cell surface.
Present results also demonstrated that cardiomyocyte growth in response to the AR agonists can be controlled by manipulating the AR transport in the early secretary pathway. Consistent with the effect of Rab1 on the cell surface expression and signaling of β-AR and α 1 -AR, Rab1 selectively promoted PE-mediated hypertrophy, as measured by changes in total protein synthesis in neonatal cardiomyocytes, and Rab1N124I attenuated both PE and ISO-stimulated cardiomyocyte hypertrophy. We previously demonstrated that, similar to α 1 -AR, expression of Rab1 and Rab1N124I produced opposing effects on hypertrophic response to Ang II (Filipeanu et al., 2004) . These data indicate that cardiomyocyte growth can be manipulated by controlling the transport of G protein-coupled receptors at the level of the ER and This article has not been copyedited and formatted. The final version may differ from this version. We have shown that transgenic overexpression of Rab1 in the myocardium induces cardiac hypertrophy with progression to heart failure (Wu et al., 2001 ). However, the molecular mechanism responsible for Rab1-induced cardiomyocyte hypertrophy remains unknown. We have demonstrated that
Rab1 promoted AT1R-and α 1 -AR-mediated signaling and cardiomyocyte growth. These data suggest that one of the possible molecular mechanisms underlying Rab1-induced hypertrophy in transgenic mouse hearts is that Rab1 overexpression activates signal transduction pathways of Gq-coupled AT1R
and α 1 -AR. This possibility is supported by the abilities of AT1R and α 1 -AR activation to induce cardiomyocyte hypertrophic growth both in vivo animal hearts and in vitro cultured cardiomyocytes (Sadoshima and Izumo, 1993; Knowlton et al, 1993; Milano et al., 1994; Paradis et al., 2000) .
This article has not been copyedited and formatted. The final version may differ from this version. In summary we have shown for the first time a differential role of Rab1 in the transport and function of ARs, which are crucial for cardiac function under both normal and diseased conditions. Therefore, defining the functional role of export machinery (e. g. Rab1 GTPase) in cardiomyocytes by modifying the transport of selective G protein-coupled receptors in the early secretory pathway may provide a novel insight into understanding the regulation of these clinically important targets.
